首页> 外文期刊>Indian medical journal >Evaluation of Safety and Efficacy of Clarina anti-acne face mask in the Treatment of Mild to Moderate Acne-Vulgaris:An Open Clinical Study
【24h】

Evaluation of Safety and Efficacy of Clarina anti-acne face mask in the Treatment of Mild to Moderate Acne-Vulgaris:An Open Clinical Study

机译:克拉丽娜抗痤疮面膜治疗轻度至中度寻常型寻常型痤疮的安全性和有效性评估:一项开放的临床研究

获取原文
获取原文并翻译 | 示例
           

摘要

Acne vulgaris is a chronic inflammatory disease of the pilosebaceous follicle, characterised by comedones, papules, pustules, cysts, nodules and often scars in certain sites of predilection, namely, the face, neck, upper trunk and arms. The purpose of the study was to evaluate efficacy and safety of Clarina anti-acne face mask for the treatment of mild to moderate acne vulgaris. Ninety six subjects aged between 18 to 34 years suffering from mild to moderate acne vulgaris and who were willing to give informed written consent were included in the study. After obtaining informed consent, baseline history was obtained and all patients underwent a clinical examination and thorough skin examination. Patients were advised to apply Clarina anti-acne face mask evenly over cleansed face and neck avoiding the area around the eyes. Patients were instructed to allow the mask to dry for 10-15 minutes, remove with wet sponge and wash the skin with cool water. The response to therapy was evaluated at intervals of two weeks upto the six weeks by calculating the acne lesion score (ALS). During each follow-up visit, local skin examination was done and observations recorded in the structured case record sheet. Out of 96 patients, 27 patients presented with normal to dry skin, 12 patients with dry skin, 20 patients with normal'to oily skin and 37 patients with oily skin. Response to the treatment was observed at every two weeks interval. At the end of 6 weeks treatment, 8 patients showed excellent response, 22 patients showed a good response, 47 patients showed moderate response and 12 patients showed poor response.
机译:寻常痤疮是一种慢性炎症性皮脂腺滤泡性疾病,其特征是粉刺,丘疹,脓疱,囊肿,结节以及在某些偏爱部位(即面部,颈部,上躯干和手臂)经常有疤痕。这项研究的目的是评估Clarina抗痤疮面膜治疗轻度至中度寻常性痤疮的功效和安全性。这项研究包括了96名年龄在18至34岁之间的患有轻度至中度寻常型痤疮并且愿意给出知情书面同意的受试者。获得知情同意后,获得基线病史,所有患者均接受临床检查和彻底的皮肤检查。建议患者在清洁的脸部和颈部均匀涂抹Clarina抗粉刺面膜,避免眼睛周围区域。指示患者使面罩干燥10-15分钟,用湿海绵去除,然后用冷水清洗皮肤。通过计算痤疮病变评分(ALS),每两周至六周评估一次对治疗的反应。在每次随访中,进行局部皮肤检查并将观察结果记录在结构化病例记录表中。在96例患者中,有27例表现为中度至干性皮肤,12例为干燥性皮肤,20例为中度至油性皮肤,37例为油性皮肤。每两周观察一次对治疗的反应。在治疗的6周结束时,有8例显示出良好的反应,22例显示出良好的反应,47例显示出中度反应,12例显示出不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号